About Index Trending news
Analyze
Pricing
CeQur

CeQur

CeQur

CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
I work here Suggest edits
More info

Elsewhere

Contributors to this profile

Companies in the same industry

Edwards Lifesciences Edwards Lifesciences Kymab Ltd Kymab Ltd Smith & Nephew plc Smith & Nephew plc InVivo Therapeutics InVivo Therapeutics CONNECT CONNECT RODO Medical RODO Medical Adient Medical, Inc. Adient Medical, Inc. Mirexus Biotechnologies Mirexus Biotechnologies Kickstart/Cadence Biomedical Kickstart/Cadence Biomedical Indie Bio SF Indie Bio SF

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Venture capital (Series C)
$100,000,000
Endeavour Vision, Woodford Investment Management, VI Partners, +2
Venture capital (Series B)
$27,000,000
Employees

Team size

50+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CeQur makes some noise.